MetaCap

BioLineRx Statistics

NASDAQ: BLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9639-0.0861 (-8.20%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BioLineRx by the numbers

BioLineRx has a market capitalization of $4.8 million based on 4.98M shares outstanding. With trailing EPS of $0.00, BioLineRx is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 52.3% below its 50-day average and 63.3% below its 200-day average.

Average daily trading volume is 23.43K shares, or about $22,580 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BLRX valuation vs. peer median

BLRX compared with the median of 8 peer companies
MetricBLRXPeer medianDifference
Market cap$4.80M$4.89M-2%
Avg. volume23.43K166.64K-86%

Peer median across 8 companies: PULM, SNGX, PCSA, CANF, CNSP, UPC, TOVX, SCNX.

Valuation

Price / sales (latest FY)
4.07

Price and trading

Previous close
1.05
Open
1.10
Day range
0.78 – 1.10
52-week range
0.78 – 3.95
52-week change
-70.34%
Beta
—
Volume
38.77K

Dividends and events

Annual dividend
None
Next earnings date
Nov 23, 2026

Additional statistics

Market Cap
4.80M
Forward Pe
-0.38
Eps
0.00
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.95
Week52 Low
0.78
Avg Volume
23,426.00
Shares Outstanding
4.98M
Ma50
2.02
Ma200
2.62
Earnings Date
Nov 23, 2026
Pct From52w High
-75.60%
Pct From52w Low
23.58%

Related